Lenalidomide + rituximab + ESHAP chemotherapy prior to autologous stem cell transplantation in patients with relapsed/refractory diffuse large B cell lymphoma.
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2016
At a glance
- Drugs Lenalidomide (Primary) ; Antineoplastics; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 22 Sep 2014 Status changed from not stated to completed.
- 13 Aug 2014 New trial record